Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Life events or new priorities often require tweaks; identify triggers and implement targeted changes to keep your finances on track.
19,621 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Netflix just changed how it reports engagement, and the move could ripple through NFLX stock moves. This guide breaks...
As 2026 unfolds, investors must weigh software-driven growth against hardware resilience. This guide compares Salesfo...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
Amazon stock has dropped 13% this year, even after solid quarterly results. This article breaks down what to watch, h...
As Pool Corp closes its Q4, investors weigh the implications for pool corp (pool) 2025. This guide breaks down the ea...
Costco’s price action has moved back toward the $1,000 level, prompting a careful look at whether the stock deserves ...
Investors ask if Apple stock should be bought before April 30. This guide offers a clear framework, real-world exampl...
When figma stock popped today, investors watched for catalysts beyond a single headline. This guide breaks down the d...
As Warren Buffett closes one chapter, a decisive last quarter move offers a powerful lesson in patience, discipline, ...
Howard Marks has publicly shifted his stance on AI after a Claude tutorial, urging investors to balance opportunity w...
If you’re searching for a medical-device stock you can own for decades, Medtronic stands out. This article breaks dow...